A

Amylyx Pharmaceuticals
D

AMLX

5.54500
USD
0.10
(1.84%)
Market Open
Volume
6,977
EPS
-4
Div Yield
-
P/E
-1
Market Cap
380,097,884
News

Title: Amylyx Pharmaceuticals

Sector: Healthcare
Industry: Biotechnology
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder.